NVTS:NASDAQNavitas Semiconductor Corporation Analysis
Data as of 2026-07-16 - not real-time
$11.76
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Navitas Semiconductor is trading well below its discounted cash‑flow estimate, making the stock appear significantly overvalued on a price‑to‑fair‑value basis. Technical indicators show a bearish MACD crossover and a neutral trend, while the RSI suggests the shares are in oversold territory, hinting at a possible short‑term bounce. Volume has been on a downtrend, reinforcing the lack of buying enthusiasm, and the beta is markedly higher than the market, amplifying price swings. Recent headlines flag a fresh patent‑infringement lawsuit from a major competitor, adding legal uncertainty to an already fragile outlook.
Fundamentally, the company reports negative operating margins, a negative EPS, and a high price‑to‑sales multiple, underscoring weak profitability and limited value appeal. Nonetheless, the firm holds a solid cash buffer relative to its modest debt load, and management is positioning the business toward high‑growth AI and EV power‑module markets, which could provide a catalyst if execution improves.
Fundamentally, the company reports negative operating margins, a negative EPS, and a high price‑to‑sales multiple, underscoring weak profitability and limited value appeal. Nonetheless, the firm holds a solid cash buffer relative to its modest debt load, and management is positioning the business toward high‑growth AI and EV power‑module markets, which could provide a catalyst if execution improves.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- bearish MACD and neutral trend
- decreasing volume and oversold RSI
- legal exposure from patent lawsuit
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- potential upside from AI and EV power markets
- strong cash position offset by negative cash flow
- high volatility and beta sustaining price uncertainty
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- overvaluation relative to DCF fair value
- persistent negative profitability metrics
- strategic pivot to advanced power materials may require time to materialize
Key Metrics & Analysis
Financial Health
Revenue Growth-38.70%
P/E Ratio-84.9
ROE-35.15%
ROA-12.76%
Debt/Equity1.51
P/B Ratio6.5
Op. Cash Flow$-45720000
Free Cash Flow$43.8M
Industry P/E33.2
Technical Analysis
TrendNeutral
RSI31.5
Support$11.57
Resistance$24.66
MA 20$16.63
MA 50$20.71
MA 200$12.63
MACDBearish
VolumeDecreasing
Fear & Greed Index91.55
Valuation
Fair Value$3.23
Target Price$14.46
Upside/Downside23.03%
GradeOvervalued
TypeBlend
Risk Assessment
Beta4.42
Volatility126.73%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.